Proteasomal cysteine deubiquitinase inhibitor b-AP15 suppresses migration and induces apoptosis in diffuse large B cell lymphoma

BACKGROUND: The first line therapy for patients with diffuse large B cell (DLBCL) is R-CHOP. About half of DLBCL patients are either refractory to, or will relapse, after the treatment. Therefore, identifying novel drug targets and effective therapeutic agents is urgently needed for improving DLBCL...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:J Exp Clin Cancer Res
Main Authors: Jiang, Liling, Sun, Yuening, Wang, Jinxiang, He, Qingyan, Chen, Xinmei, Lan, Xiaoying, Chen, Jinghong, Dou, Q. Ping, Shi, Xianping, Liu, Jinbao
Formato: Artigo
Idioma:Inglês
Publicado em: BioMed Central 2019
Assuntos:
Research
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6836452/
https://ncbi.nlm.nih.gov/pubmed/31694672
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13046-019-1446-y
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados